Literature DB >> 29025446

Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa.

Bvudzai P Magadzire1, Kim Ward, Henry M J Leng, David Sanders.   

Abstract

BACKGROUND: South Africa (SA) has experienced several stock-outs of life-saving medicines for the treatment of major chronic infectious and non-communicable diseases in the public sector.
OBJECTIVE: To identify the causes of stock-outs and to illustrate how they undermine access to medicines (ATM) in the Western Cape Province, SA.
METHODS: This qualitative study was conducted with a sample of over 70 key informants (frontline health workers, sub-structure and provincial health service managers). We employed the critical incident technique to identify significant occurrences in our context, the consequences of which impacted on access to medicines during a defined period. Stock-outs were identified as one such incident, and we explored when, where and why they occurred, in order to inform policy and practice.
RESULTS: Medicines procurement is a centralised function in SA. Health service managers unanimously agreed that stock-outs resulted from the following inefficiencies at the central level: (i) delays in awarding of pharmaceutical tenders; (ii) absence of contracts for certain medicines appearing on provincial code lists; and (iii) suppliers' inability to satisfy contractual agreements. The recurrence of stock-outs had implications at multiple levels: (i) health facility operations; (ii) the Chronic Dispensing Unit (CDU), which prepacks medicines for over 300 000 public sector patients; and (iii) community-based medicines distribution systems, which deliver the CDU's prepacked medicines to non-health facilities nearer to patient homes. For instance, stock-outs resulted in omission of certain medicines from CDU parcels that were delivered to health facilities. This increased workload and caused frustration for frontline health workers who were expected to dispense omitted medicines manually. According to frontline health workers, this translated into longer waiting times for patients and associated dissatisfaction. In some instances, patients were asked to return for undispensed medication at a later date, which could potentially affect adherence to treatment and therapeutic outcomes. Stock-outs therefore undermined the intended benefits of ATM strategies.
CONCLUSION: Addressing the procurement challenges, most notably timeous tender awards and supplier performance management, is critical for successful implementation of ATM strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29025446     DOI: 10.7196/SAMJ.2017.v107i7.11356

Source DB:  PubMed          Journal:  S Afr Med J


  8 in total

1.  Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages.

Authors:  Magdalena P Bravo; Meridith Blevins Peratikos; Amina S Muicha; Epifanio Mahagaja; Maria Fernanda Sardella Alvim; Ann F Green; C William Wester; Sten H Vermund
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-02       Impact factor: 2.205

2.  Evaluating the availability of essential drugs for hypertension, diabetes and asthma in rural Rwanda, 2018.

Authors:  F Mbonyinshuti; K C Takarinda; S Ade; M Manzi; P G Iradukunda; J Kabatende; T Habiyaremye; P C Kayumba
Journal:  Public Health Action       Date:  2021-03-21

3.  Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.

Authors:  Avram E Denburg; Adam Fundytus; Muhammad Saghir Khan; Scott C Howard; Federico Antillon-Klussmann; Manju Sengar; Dorothy Lombe; Wilma Hopman; Matthew Jalink; Bishal Gyawali; Dario Trapani; Felipe Roitberg; Elisabeth G E De Vries; Lorenzo Moja; André Ilbawi; Richard Sullivan; Christopher M Booth
Journal:  JCO Glob Oncol       Date:  2022-06

4.  Stock-outs of antiretroviral and tuberculosis medicines in South Africa: A national cross-sectional survey.

Authors:  Bella Hwang; Amir Shroufi; Tinne Gils; Sarah Jane Steele; Anna Grimsrud; Andrew Boulle; Anele Yawa; Sasha Stevenson; Lauren Jankelowitz; Marije Versteeg-Mojanaga; Indira Govender; John Stephens; Julia Hill; Kristal Duncan; Gilles van Cutsem
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

5.  Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers.

Authors:  Muhammad Atif; Iram Malik; Irem Mushtaq; Saima Asghar
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

6.  Process evaluation of the central chronic medicines dispensing and distribution programme in Namakwa district, Northern Cape province protocol: a multimethod approach.

Authors:  Kim Grace Smith; Edward Nicol
Journal:  BMJ Open       Date:  2020-02-04       Impact factor: 2.692

7.  Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship-A Tale of Two Countries.

Authors:  Lucille Malan; Quinten Labuschagne; Erich Brechtelsbauer; Debra A Goff; Natalie Schellack
Journal:  Front Public Health       Date:  2018-11-14

8.  Health system determinants of access to essential medicines for children with cancer in Ghana.

Authors:  Rhonda Boateng; Lorna Renner; Kadia Petricca; Sumit Gupta; Avram Denburg
Journal:  BMJ Glob Health       Date:  2020-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.